LBR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.419400E-01
Normal-vs-Stage2
4.358600E-01
Normal-vs-Stage3
2.393600E-01
Normal-vs-Stage4
5.194400E-01
Stage1-vs-Stage2
9.314200E-01
Stage1-vs-Stage3
2.268000E-01
Stage1-vs-Stage4
7.514600E-01
Stage2-vs-Stage3
1.071780E-01
Stage2-vs-Stage4
6.697200E-01
Stage3-vs-Stage4
4.622700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.963900E-02
Normal-vs-AfricanAmerican
4.976200E-01
Normal-vs-Asian
3.881000E-01
Caucasian-vs-AfricanAmerican
1.791010E-01
Caucasian-vs-Asian
7.758600E-01
AfricanAmerican-vs-Asian
7.077900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.694000E-02
Normal-vs-Female
4.053600E-01
Male-vs-Female
8.620000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.164000E-01
Normal-vs-Age(41-60Yrs)
4.411600E-01
Normal-vs-Age(61-80Yrs)
5.568200E-02
Normal-vs-Age(81-100Yrs)
4.403600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.347200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.381400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.898600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.130800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.448000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.125000E-01
Normal-vs-Daily Drinker
3.181200E-01
Normal-vs-Weekly Drinker
1.060380E-01
Normal-vs-Occasional Drinker
3.928800E-01
Normal-vs-Social Drinker
1.804360E-01
Non Drinker-vs-Daily Drinker
1.846210E-01
Non Drinker-vs-Weekly Drinker
9.235800E-01
Non Drinker-vs-Occasional Drinker
7.934000E-01
Non Drinker-vs-Social Drinker
9.700600E-01
Daily Drinker-vs-Weekly Drinker
3.227400E-01
Daily Drinker-vs-Occasional Drinker
3.490600E-01
Daily Drinker-vs-Social Drinker
3.583000E-01
Weekly Drinker-vs-Occasional Drinker
8.961200E-01
Weekly Drinker-vs-Social Drinker
9.692400E-01
Occasional Drinker-vs-Social Drinker
8.772000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.446200E-01
Normal-vs-Grade 2
5.765800E-02
Normal-vs-Grade 3
6.668200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.605000E-01
Grade 1-vs-Grade 3
2.220600E-01
Grade 1-vs-Grade 4
3.446200E-01
Grade 2-vs-Grade 3
5.032400E-01
Grade 2-vs-Grade 4
5.765800E-02
Grade 3-vs-Grade 4
6.668200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.722100E-02
Normal-vs-NonDiabetic
3.734000E-01
Diabetic-vs-NonDiabetic
8.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.606610E-01
Normal-vs-NoPancreatitis
3.772600E-01
Pancreatitis-vs-NoPancreatitis
7.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.026300E-02
Normal-vs-N1
4.191000E-01
N0-vs-N1
8.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.000400E-01
Normal-vs-TP53-NonMutant
1.843370E-01
TP53-Mutant-vs-TP53-NonMutant
7.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
